PNC Managed Account Solutions’s AbbVie ABBV Stock Holding History

PNC Managed Account Solutions’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$820K	Buy	+7,284	New	+$820K	0.16%	88

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

PNC Managed Account Solutions's ABBV Position: Q2 2021 in Review

PNC Managed Account Solutions opened a new position in AbbVie (ABBV) in Q2 2021: 7,284 shares worth $820K. The stake represents 0.16% of the portfolio and ranks #88 among its holdings.

2,676 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

PNC Managed Account Solutions held 7,284 shares of AbbVie worth $820K as of Q2 2021.
AbbVie was a new PNC Managed Account Solutions position in Q2 2021.
AbbVie made up 0.16% of PNC Managed Account Solutions's portfolio in Q2 2021, its #88 holding.
2,676 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on PNC Managed Account Solutions's 13F filing for Q2 2021, filed 6 Aug 2021.